Breast Lift in Italy
Breast Lift in Italy section, includes general infrmation about Breast Lift Procedure, Breast Lift Italy Local News, Breast Lift Italy Surgeon Locator and other Breast Lift related material.
Breast Lift Procedure
A mastopexy or breast lift is a surgical procedure performed to reshape the breast and return it to a more youthful position. Drooping of the breast may occur after pregnancy as well as aging. Frequently a breast implant may be used in conjunction with a breast lift in order to achieve better results. Depending on the amount of breast lifting that needs to be accomplished, different techniques may be used that involve different incisions. Generally, the more lifting that is required, the larger the incision (and therefore the scar).
Other Breast Lift Procedures
All Breast Procedures
Breast Lift Italy (current)
Italy Breast Reduction
Italy Breast Implants
Italy Implant Removal
Italy Armpit Incision
More Italy info...
Italy Cities Of the hundreds of Italian cities, here are nine of its most famous:
Rome - (Roma): the capital, both of Italy and of the ancient Roman Empire; center of the Roman Catholic Church (the Vatican).
Bologna - A major trade fair city.
Florence - (Firenze): History, art, architecture. Uffizi gallery, David of Michelangelo Buonarroti.
Genoa - (Genova) a vibrant and historical port city, birth place of Columbus.
Milan - (Milano) - shares with Paris the title of fashion capital of the world and is the main financial and business centre in the country.
Naples - (Napoli) with its famous gulf and Vesuvius volcano, including Herculaneum and Pompeii.
Italy Further reading Non-guidebooks about Italy or by Italian writers.
The Travels of Marco Polo by Marco Polo - stories about China by the Venetian traveller
Winter Stars by Beatrice Lao - poems born between the Alps and the Tyrrhenian by the oriental poetess, 988979991X
The Agony and the Ecstasy by Irving Stone - a biography of Michelangelo that also paints a lovely portrait of Tuscany and Rome
Plastic Surgery News...
- Regenerx Biopharmaceuticals, Inc. (Amex:Rgn) announced that Dr.
- The European Medicines Agency’s (EMEA) has issued a public statement on the risk of peripheral neuropathy with Sebivo® (telbivudine). The statement is given below (direct from source):
The European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) has recommended that new warnings be included in the product information for Sebivo (telbivudine), from Novartis Europharm Ltd. This warning is intended to inform doctors about the risk of peripheral neuropathy in patients with chronic hepatitis B who are being treated with Sebivo.
Doctors are advised to monitor patients carefully for signs of peripheral neuropathy and to reconsider treatment options if they suspect that a patient is developing peripheral neuropathy. Sebivo is indicated for the treatment of chronic hepatitis B in adult patients with compensated liver disease and evidence of viral replication, persistently elevated serum alanine aminotransferase (ALT) levels and histological evidence of active inflammation and/or fibrosis as monotherapy only.
Cases of peripheral neuropathy have been uncommonly reported in patients treated with telbivudine as monotherapy. In a clinical trial investigating the combination therapy of telbivudine 600 mg daily with pegylated interferon alfa-2a 180 mcg once weekly, an increased risk of peripheral neuropathy was observed.
The CHMP, after evaluating the available data, has recommended the inclusion of the following warning in the product information for Sebivo:
Peripheral neuropathy has been uncommonly reported in telbivudine-treated patients. If peripheral neuropathy is suspected, treatment with telbivudine should be reconsidered (see section 4.8).
An increased risk of peripheral neuropathy has been observed when telbivudine and pegylated interferon alfa-2a are co-administered (see section 4.5). Such increased risk cannot be excluded for other interferons alfa (pegylated or standard). Moreover, the benefit of this combination of telbivudine with interferon alfa (pegylated or standard) is not currently established.
The statement can be accessed at the above link.